IL6 and COVID-19: In patients with COVID-19, the mean VR [2.05 (0.42) vs. 1.77 (0.24), P = 0.001] and IL-6 [721.27 (645.44) vs. 148.89 (179.80), P < 0.001] were significantly higher in those who developed a PE (Table 4).